Acoustic Stimulation During Sleep Could Improve Cardiac Health
Gentle noise stimulation synchronized with an individual’s brainwaves boosted cardiovascular health, according to a recent study.
Yearly Archives: 2019
Scientists Identify Therapeutic Target in Diabetic Kidney Disease
In a study published in the Journal of Experimental Medicine, Northwestern Medicine scientists identified a new therapeutic target that may help protect kidney function in patients with diabetes.
Medical Students Celebrate Match Day 2019
On Match Day, fourth-year medical students learned where they will spend the next phase of their medical careers.
Eating Eggs and Cholesterol Linked to Heart Disease and Death Risk
Increased consumption of eggs and dietary cholesterol is linked to a significantly higher risk of cardiovascular disease and death, according to a new study.
Medical Honor Society Welcomes 2019 Inductees
Forty new members were inducted into Northwestern’s chapter of the Alpha Omega Alpha medical honor society during a ceremony on March 12.
Findings Overturn Old Assumptions in Maternal Care
Northwestern investigators are building a multi-disciplinary enterprise that is making critical discoveries in maternal-fetal health, with significant clinical implications and real-world consequences.
Ardehali Elected President of ASCI
Hossein Ardehali, MD, PhD, was elected president of the American Society for Clinical Investigation, an honor society of physician-scientists founded in 1908.
Feinberg Ranks Among Top Medical Schools in the Nation
Feinberg has been named as one of the top 20 best research-oriented medical schools in the country, according to the latest U.S. News & World Report rankings.
Tumor Mutations Predict Response to Immunotherapy
A recent Northwestern Medicine study found that patients with glioblastoma responded better or worse to immunotherapy depending on the presence of certain mutations in their tumors.
Alzheimer’s Treatment Holds Promise for Primary Progressive Aphasia Patients
Northwestern Medicine scientists have discovered that an existing therapy used to treat Alzheimer’s disease might also work on patients with Primary Progressive Aphasia, a type of dementia that destroys language and currently has no treatment.